Role of Body-Fluid Biomarkers in Alzheimer's Disease Diagnosis

被引:18
作者
Nguyen, Thuy Trang [1 ]
Ta, Qui Thanh Hoai [2 ]
Nguyen, Thi Kim Oanh [3 ]
Nguyen, Thi Thuy Dung [4 ]
Vo, Van Giau [5 ,6 ]
机构
[1] Ho Chi Minh City Univ Technol HUTECH, Fac Pharm, Ho Chi Minh City 700000, Vietnam
[2] Duy Tan Univ, Inst Res & Dev, Danang 550000, Vietnam
[3] Ho Chi Minh City Univ Food Ind, Fac Food Sci & Technol, Ho Chi Minh City 700000, Vietnam
[4] Nguyen Tat Thanh Univ, Fac Environm & Food Engn, Ho Chi Minh City 70000, Vietnam
[5] Gachon Univ, Grad Sch Environm, Dept Ind & Environm Engn, 1342 Sungnam Daero, Seongnam Si 461701, Gyeonggi Do, South Korea
[6] Gachon Univ, Dept BionanoTechnol, 1342 Sungnam Daero, Seongnam Si 461701, Gyeonggi Do, South Korea
基金
新加坡国家研究基金会;
关键词
Alzheimer's disease; biomarkers; diagnostics; A beta; CSF; tau; MILD COGNITIVE IMPAIRMENT; PLASMA AMYLOID-BETA; HUMAN CEREBROSPINAL-FLUID; CSF BIOMARKERS; PHOSPHORYLATED-TAU; SYNAPTIC DEGENERATION; OCULAR BIOMARKERS; PRECURSOR PROTEIN; PATHOLOGY; DECLINE;
D O I
10.3390/diagnostics10050326
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Alzheimer's disease (AD) is a complex neurodegenerative disease that requires extremely specific biomarkers for its diagnosis. For current diagnostics capable of identifying AD, the development and validation of early stage biomarkers is a top research priority. Body-fluid biomarkers might closely reflect synaptic dysfunction in the brain and, thereby, could contribute to improving diagnostic accuracy and monitoring disease progression, and serve as markers for assessing the response to disease-modifying therapies at early onset. Here, we highlight current advances in the research on the capabilities of body-fluid biomarkers and their role in AD pathology. Then, we describe and discuss current applications of the potential biomarkers in clinical diagnostics in AD.
引用
收藏
页数:17
相关论文
共 138 条
[1]   Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ42 [J].
An, Seong Soo A. ;
Lee, Byoung-sub ;
Yu, Ji Sun ;
Lim, Kuntaek ;
Kim, Gwang Je ;
Lee, Ryan ;
Kim, Shinwon ;
Kang, Sungmin ;
Park, Young Ho ;
Wang, Min Jeong ;
Yang, Young Soon ;
Youn, Young Chul ;
Kim, SangYun .
ALZHEIMERS RESEARCH & THERAPY, 2017, 9
[2]   Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment [J].
Andreasen, N ;
Minthon, L ;
Vanmechelen, E ;
Vanderstichele, H ;
Davidsson, P ;
Winblad, B ;
Blennow, K .
NEUROSCIENCE LETTERS, 1999, 273 (01) :5-8
[3]   Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice [J].
Andreasen, N ;
Minthon, L ;
Davidsson, P ;
Vanmechelen, E ;
Vanderstichele, H ;
Winblad, B ;
Blennow, K .
ARCHIVES OF NEUROLOGY, 2001, 58 (03) :373-379
[4]   Update on biomarkers for amyloid pathology in Alzheimer's disease [J].
Ashton, Nicholas J. ;
Schoell, Michael ;
Heurling, Kerstin ;
Gkanatsiou, Eleni ;
Portelius, Erik ;
Hoeglund, Kina ;
Brinkmalm, Gunnar ;
Hye, Abdul ;
Blennow, Kaj ;
Zetterberg, Henrik .
BIOMARKERS IN MEDICINE, 2018, 12 (07) :799-812
[5]   Novel amyloid precursor protein mutation, Val669Leu ("Seoul APP"), in a Korean patient with early-onset Alzheimer's disease [J].
Bagyinszky, Eva ;
Kang, Min Ju ;
Vo Van Giau ;
Shim, KyuHwan ;
Pyun, Jung-Min ;
Suh, Jeewon ;
An, Seong Soo A. ;
Kim, SangYun .
NEUROBIOLOGY OF AGING, 2019, 84 :236.e1-236.e7
[6]   Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis [J].
Bagyinszky, Eva ;
Vo Van Giau ;
Shim, Kyuhwan ;
Suk, Kyoungho ;
An, Seong Soo A. ;
Kim, SangYun .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 376 :242-254
[7]   A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease [J].
Barthelemy, Nicolas R. ;
Li, Yan ;
Joseph-Mathurin, Nelly ;
Gordon, Brian A. ;
Hassenstab, Jason ;
Benzinger, Tammie. L. S. ;
Buckles, Virginia ;
Fagan, Anne M. ;
Perrin, Richard J. ;
Goate, Alison M. ;
Morris, John C. ;
Karch, Celeste M. ;
Xiong, Chengjie ;
Allegri, Ricardo ;
Mendez, Patricio Chrem ;
Berman, Sarah B. ;
Ikeuchi, Takeshi ;
Mori, Hiroshi ;
Shimada, Hiroyuki ;
Shoji, Mikio ;
Suzuki, Kazushi ;
Noble, James ;
Farlow, Martin ;
Chhatwal, Jasmeer ;
Graff-Radford, Neill R. ;
Salloway, Stephen ;
Schofield, Peter R. ;
Masters, Colin L. ;
Martins, Ralph N. ;
O'Connor, Antoinette ;
Fox, Nick C. ;
Levin, Johannes ;
Jucker, Mathias ;
Gabelle, Audrey ;
Lehmann, Sylvain ;
Sato, Chihiro ;
Bateman, Randall J. ;
McDade, Eric ;
Allegri, Ricardo ;
Allegri, Ricardo ;
Bateman, Randy ;
Bechara, Jacob ;
Benzinger, Tammie ;
Berman, Sarah ;
Bodge, Courtney ;
Brandon, Susan ;
Brooks, William ;
Buck, Jill ;
Buckles, Virginia ;
Chea, Sochenda .
NATURE MEDICINE, 2020, 26 (03) :398-+
[8]   Another step forward in blood-based diagnostics for Alzheimer's disease [J].
Bateman, Randall J. ;
Barthelemy, Nicolas R. ;
Horie, Kanta .
NATURE MEDICINE, 2020, 26 (03) :314-316
[9]   Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease [J].
Bateman, Randall J. ;
Xiong, Chengjie ;
Benzinger, Tammie L. S. ;
Fagan, Anne M. ;
Goate, Alison ;
Fox, Nick C. ;
Marcus, Daniel S. ;
Cairns, Nigel J. ;
Xie, Xianyun ;
Blazey, Tyler M. ;
Holtzman, David M. ;
Santacruz, Anna ;
Buckles, Virginia ;
Oliver, Angela ;
Moulder, Krista ;
Aisen, Paul S. ;
Ghetti, Bernardino ;
Klunk, William E. ;
McDade, Eric ;
Martins, Ralph N. ;
Masters, Colin L. ;
Mayeux, Richard ;
Ringman, John M. ;
Rossor, Martin N. ;
Schofield, Peter R. ;
Sperling, Reisa A. ;
Salloway, Stephen ;
Morris, John C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (09) :795-804
[10]   Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach [J].
Bereczki, Erika ;
Branca, Rui M. ;
Francis, Paul T. ;
Pereira, Joana B. ;
Baek, Jean-Ha ;
Hortobagyi, Tibor ;
Winblad, Bengt ;
Ballard, Clive ;
Lehtio, Janne ;
Aarsland, Dag .
BRAIN, 2018, 141 :582-595